LINDY MORRIS FISHBURNE

Lindy Morris Fishburne stands as a prominent figure in the venture capital landscape, serving as the Managing Partner at Breakout Ventures. Her leadership at the firm is instrumental in identifying and cultivating early-stage companies that are pioneering advancements at the crucial intersection of biology and technology. Breakout Ventures, under her guidance, is dedicated to backing visionary founders who are leveraging biological innovation to create transformative solutions across a multitude of industries.

At Breakout Ventures, Lindy's role extends beyond capital allocation; she is deeply involved in shaping the strategic direction of the firm and mentoring portfolio companies. Her expertise lies in recognizing the potential of nascent technologies that are "breaking out" of traditional scientific silos. The firm's investment thesis, heavily influenced by her vision, centers on areas such as synthetic biology, computational biology, advanced materials, and the application of biological principles to food, agriculture, and human health. This focus targets companies developing novel platforms and products that promise to redefine manufacturing, medicine, and sustainability.

Before co-founding Breakout Ventures, Lindy Morris Fishburne built a robust career foundation that equipped her with a unique perspective on deep technology investing. She previously served as a partner at Harris & Harris Group, an early-stage venture capital firm renowned for its investments in nanotechnology and advanced materials. This experience provided her with invaluable insights into the complexities of commercializing cutting-edge scientific discoveries and navigating the challenges of deep tech startups. Her tenure there solidified her reputation as an astute investor with a keen eye for disruptive innovation.

Lindy's academic background further underpins her success. She holds a Juris Doctor from the University of Virginia School of Law and a Bachelor of Arts from the University of North Carolina at Chapel Hill. Her legal training, including a period as a law clerk for the Honorable James C. Cacheris and as a corporate attorney at Cooley LLP, honed her analytical skills and understanding of corporate governance and intellectual property, critical components in the highly specialized fields Breakout Ventures invests in. This blend of legal acumen and venture capital experience allows her to provide comprehensive support to the innovative companies in Breakout's portfolio.

Through her work at Breakout Ventures, Lindy Morris Fishburne is not just funding companies; she is actively fostering an ecosystem where scientific breakthroughs translate into tangible, impactful products and services. Her commitment to the bio-tech convergence is driving forward companies that are poised to solve some of the world's most pressing challenges, from sustainable food production to revolutionary medical treatments and environmentally friendly industrial processes. Her leadership ensures that Breakout Ventures remains at the forefront of investing in the future of biology-driven innovation.